Question follow-through · 77949

Cerliponase Alfa

To ask the Secretary of State for Health and Social Care, what discussions he has had with the National Institute for Health and Care Excellence on securing long term access to cerliponase alfa.

answeredDepartment of Health and Social Care

About this written question

A written question asks a government minister for information in writing. Parliament publishes the question and any answer.

Answering body: Department of Health and Social Care
Tabled: 16 Sept 2025
Target answer date: 14 Oct 2025
Answer: 14 Oct 2025 · 28 calendar days after tabling

Elapsed calendar days describe the record timeline, not whether Parliament considers an answer on time.

Votes on this topic

Terminally Ill Adults (End of Life) Bill: Second Reading · 11 Sept 2026
Health Bill: Report Stage: Amendment 1 · 8 Sept 2026
Health Bill: Report Stage: New Clause 143 · 8 Sept 2026

These Commons divisions share a topic label. The question did not necessarily lead to a vote.

Recorded timeline

16 Sept 2025
Question tabled
To ask the Secretary of State for Health and Social Care, what discussions he has had with the National Institute for Health and Care Excellence on securing long term access to cerliponase alfa.
14 Oct 2025
Target answer date
Date supplied by the official written-questions record.
14 Oct 2025
Answer published
Officials in the Department have had a number of discussions with colleagues in the National Institute for Health and Care Excellence (NICE) about the ongoing appraisal of cerliponase alfa (Brineura) for the treatment of neuronal ceroid lipofuscinosis typ...

Open official record

Official data retrieved 28 Sept 2026.

Later records

Possible follow-up questions

Strong links require the same MP, department and exact heading. Other same-department questions are shown as unreviewed candidates, not as confirmed follow-ups. No debate link is asserted unless a stable source relationship exists.